SAG/RBX2/ROC2/RNF7 dual E3 ligase: From target identification, validation to drug discovery

Puntos clave

• This analysis shows a potential pathway for drug discovery involving dual E3 ligase.
• Key findings reveal multiple target biomarkers that could enhance treatment efficacy.
• The approach focuses on target identification and validation in biomarker development.
• Significance lies in its implications for therapeutic strategies in disease management.